Close

Wedbush Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral

August 8, 2022 6:49 AM EDT Send to a Friend
Wedbush analyst Laura Chico downgraded Biohaven Pharmaceutical Holding (NYSE: BHVN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login